Video Lectures

View video lectures on hot topics and challenging cases presented by world experts

Psoriasis News

Lilly Announces Superiority of Taltz® (ixekizumab) versus TREMFYA® (guselkumab) in Delivering Total Skin Clearance at Week 12 in Topline Results from Head-to-Head (IXORA-R) Trial in People Living with Moderate to Severe Plaque Psoriasis

8/20/2019 10:08:00 AM

Eli Lilly and Company (NYSE: LLY) announced that Taltz® (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R study, which evaluated the efficacy and safety of Taltz versus TREMFYA® (guselkumab) in people living with moderate to severe plaque psoriasis (PsO).

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease

8/6/2019 11:36:00 AM

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.

Updated Disease Classification System Adopted by the World Health Organization

8/1/2019 7:19:00 AM

On 25 May 2019, the World Health Assembly officially adopted the eleventh revision of the International Classification of Diseases (ICD-11). The ICD-11 will come into effect on 1 January 2022.

FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)

8/1/2019 7:09:00 AM

Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® (adalimumab)i , for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, and plaque psoriasis. Please see full indications and Boxed Warning for HADLIMA™, below.

More News

Psoriasis News

the latest news from ipc, industry and others

Video Lectures

Alopecia y psoriasis y Psoriasis y VPH: asociación infrecuente

Psoriasis in Special Populations & Differential Diagnostics in Psoriasis

Conozca a los Expertos de IPC - Introducción

Clinical Challenges in Psoriasis

Advances in Psoriasis

Psoriasis & Atopic Dermatitis - Symposium Closing

Psoriasis & Atopic Dermatitis - Immune Pathways

Individualizing Treatment in Psoriasis

Search Reviews:

Filter by Topic:

Psoriasis News

Advancing Knowledge. Enhancing Care.